Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. Employee Directory
Biotechnology ResearchNorth Carolina, United States51-200 Employees
Bamboo Therapeutics, Inc., a wholly owned subsidiary of Pfizer Inc., is a biotechnology research entity based in Chapel Hill, North Carolina. The company concentrates on neurological and neuromuscular diseases that affect children, with a lead gene therapy product aimed at Duchenne muscular dystrophy. Its work centers on a proprietary adeno-associated virus platform and a scaled-up manufacturing process conducted at a GMP vector core facility recently acquired by the company. Bamboo positions itself within the biotechnology research industry as a developer of innovative therapies for rare pediatric conditions, leveraging its specialized platform and established manufacturing capabilities to pursue clinical development of its therapeutics. The organization describes a collaborative community spanning researchers, clinicians, regulatory scientists, and other professionals, all dedicated to developing potential treatments for debilitating diseases. Interpreting the provided context, its primary focus is on advancing gene therapies for neuromuscular and central nervous system–related conditions in children, through ongoing research and development within a regulated production environment.
1-888-653-2347 
support@leadiq.com 
